ZA200601179B - Cosmetic composition promoting oxygen transport into the skin - Google Patents

Cosmetic composition promoting oxygen transport into the skin Download PDF

Info

Publication number: ZA200601179B
Authority: ZA; South Africa
Prior art keywords: weight; cosmetic composition; composition according; oxygen; cosmetic
Prior art date: 2003-08-11

Application number

ZA200601179A

Other languages

English (en)

Inventor

Blume Gabriele

Sacher Michael

Teichmueller Dirk

Original Assignee

Rovi Gmbh & Co Kosmetische Roh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-08-11

Filing date

2004-08-04

Publication date

2007-04-25

2004-08-04 Application filed by Rovi Gmbh & Co Kosmetische Roh filed Critical Rovi Gmbh & Co Kosmetische Roh

2007-04-25 Publication of ZA200601179B publication Critical patent/ZA200601179B/en

Links

239000000203 mixture Substances 0.000 title claims abstract description 108
239000002537 cosmetic Substances 0.000 title claims abstract description 59
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 title claims abstract description 54
239000001301 oxygen Substances 0.000 title claims abstract description 54
229910052760 oxygen Inorganic materials 0.000 title claims abstract description 54
230000001737 promoting effect Effects 0.000 title 1
NBVXSUQYWXRMNV-UHFFFAOYSA-N fluoromethane Chemical compound FC NBVXSUQYWXRMNV-UHFFFAOYSA-N 0.000 claims abstract description 24
150000003408 sphingolipids Chemical class 0.000 claims abstract description 20
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 20
239000003921 oil Substances 0.000 claims description 18
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 12
DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 12
239000002202 Polyethylene glycol Substances 0.000 claims description 11
235000019198 oils Nutrition 0.000 claims description 11
229920001223 polyethylene glycol Polymers 0.000 claims description 11
239000001993 wax Substances 0.000 claims description 11
235000011187 glycerol Nutrition 0.000 claims description 10
235000014113 dietary fatty acids Nutrition 0.000 claims description 9
239000000194 fatty acid Substances 0.000 claims description 9
229930195729 fatty acid Natural products 0.000 claims description 9
125000005456 glyceride group Chemical group 0.000 claims description 9
PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 8
150000002632 lipids Chemical class 0.000 claims description 8
235000005152 nicotinamide Nutrition 0.000 claims description 8
239000011570 nicotinamide Substances 0.000 claims description 8
229960003512 nicotinic acid Drugs 0.000 claims description 8
RGOVYLWUIBMPGK-UHFFFAOYSA-N nonivamide Chemical compound CCCCCCCCC(=O)NCC1=CC=C(O)C(OC)=C1 RGOVYLWUIBMPGK-UHFFFAOYSA-N 0.000 claims description 8
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 7
229930183167 cerebroside Natural products 0.000 claims description 7
150000001784 cerebrosides Chemical class 0.000 claims description 7
-1 nicotinic acid ester Chemical class 0.000 claims description 7
229950011087 perflunafene Drugs 0.000 claims description 7
UWEYRJFJVCLAGH-IJWZVTFUSA-N perfluorodecalin Chemical compound FC1(F)C(F)(F)C(F)(F)C(F)(F)[C@@]2(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)[C@@]21F UWEYRJFJVCLAGH-IJWZVTFUSA-N 0.000 claims description 7
PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 6
150000002339 glycosphingolipids Chemical class 0.000 claims description 6
239000012528 membrane Substances 0.000 claims description 6
WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 claims description 6
239000003755 preservative agent Substances 0.000 claims description 6
235000018936 Vitellaria paradoxa Nutrition 0.000 claims description 5
241001135917 Vitellaria paradoxa Species 0.000 claims description 5
229940106189 ceramide Drugs 0.000 claims description 5
150000002812 neutral glycosphingolipids Chemical class 0.000 claims description 5
229940057910 shea butter Drugs 0.000 claims description 5
QZXMUPATKGLZAP-DXLAUQRQSA-N [(2S)-1-hexadecanoyloxy-3-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxypropan-2-yl] (9Z,12Z)-octadeca-9,12-dienoate Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](OC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC)O[C@@H]1CO[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 QZXMUPATKGLZAP-DXLAUQRQSA-N 0.000 claims description 4
150000002334 glycols Chemical class 0.000 claims description 4
229940119170 jojoba wax Drugs 0.000 claims description 4
FIJGNIAJTZSERN-DQQGJSMTSA-N monogalactosyl-diacylglycerol Chemical compound CCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCC)CO[C@@H]1O[C@@H](CO)[C@H](O)[C@H](O)[C@@H]1O FIJGNIAJTZSERN-DQQGJSMTSA-N 0.000 claims description 4
229960003966 nicotinamide Drugs 0.000 claims description 4
235000001968 nicotinic acid Nutrition 0.000 claims description 4
239000011664 nicotinic acid Substances 0.000 claims description 4
239000002562 thickening agent Substances 0.000 claims description 4
229940058015 1,3-butylene glycol Drugs 0.000 claims description 3
ZXWQZGROTQMXME-WXUJBLQXSA-N 2-hydroxy-n-[(e,2s,3r)-3-hydroxy-1-[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadec-4-en-2-yl]tetracosanamide Chemical class CCCCCCCCCCCCCCCCCCCCCCC(O)C(=O)N[C@H]([C@H](O)\C=C\CCCCCCCCCCCCC)CO[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O ZXWQZGROTQMXME-WXUJBLQXSA-N 0.000 claims description 3
235000019437 butane-1,3-diol Nutrition 0.000 claims description 3
150000001783 ceramides Chemical class 0.000 claims description 3
235000015112 vegetable and seed oil Nutrition 0.000 claims description 3
239000008158 vegetable oil Substances 0.000 claims description 3
239000012178 vegetable wax Substances 0.000 claims description 3
239000002253 acid Substances 0.000 claims description 2
239000000969 carrier Substances 0.000 claims description 2
YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 claims 4
229960002504 capsaicin Drugs 0.000 claims 2
235000017663 capsaicin Nutrition 0.000 claims 2
229960004063 propylene glycol Drugs 0.000 claims 2
TZZAKSLHHIJRLL-UHFFFAOYSA-N 4-hydroxy-3-methoxybenzamide Chemical compound COC1=CC(C(N)=O)=CC=C1O TZZAKSLHHIJRLL-UHFFFAOYSA-N 0.000 claims 1
150000001298 alcohols Chemical class 0.000 claims 1
239000007908 nanoemulsion Substances 0.000 claims 1
239000002105 nanoparticle Substances 0.000 claims 1
210000003491 skin Anatomy 0.000 abstract description 36
210000000434 stratum corneum Anatomy 0.000 abstract description 10
210000003956 transport vesicle Anatomy 0.000 abstract description 6
210000002615 epidermis Anatomy 0.000 abstract description 4
230000015572 biosynthetic process Effects 0.000 abstract description 3
150000003904 phospholipids Chemical class 0.000 description 13
210000001519 tissue Anatomy 0.000 description 13
230000036961 partial effect Effects 0.000 description 9
238000000265 homogenisation Methods 0.000 description 8
239000000839 emulsion Substances 0.000 description 7
239000002502 liposome Substances 0.000 description 7
WWUZIQQURGPMPG-UHFFFAOYSA-N (-)-D-erythro-Sphingosine Natural products CCCCCCCCCCCCCC=CC(O)C(N)CO WWUZIQQURGPMPG-UHFFFAOYSA-N 0.000 description 6
MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 6
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
WWUZIQQURGPMPG-KRWOKUGFSA-N sphingosine Chemical compound CCCCCCCCCCCCC\C=C\[C@@H](O)[C@@H](N)CO WWUZIQQURGPMPG-KRWOKUGFSA-N 0.000 description 6
239000004480 active ingredient Substances 0.000 description 5
229910001882 dioxygen Inorganic materials 0.000 description 5
150000004665 fatty acids Chemical class 0.000 description 5
239000000499 gel Substances 0.000 description 5
WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 4
241000196324 Embryophyta Species 0.000 description 4
150000001875 compounds Chemical class 0.000 description 4
239000003995 emulsifying agent Substances 0.000 description 4
238000000034 method Methods 0.000 description 4
238000002360 preparation method Methods 0.000 description 4
239000000230 xanthan gum Substances 0.000 description 4
229920001285 xanthan gum Polymers 0.000 description 4
229940082509 xanthan gum Drugs 0.000 description 4
235000010493 xanthan gum Nutrition 0.000 description 4
230000009471 action Effects 0.000 description 3
210000004027 cell Anatomy 0.000 description 3
206010012601 diabetes mellitus Diseases 0.000 description 3
238000002474 experimental method Methods 0.000 description 3
125000001153 fluoro group Chemical group F* 0.000 description 3
125000004435 hydrogen atom Chemical group [H]* 0.000 description 3
230000008569 process Effects 0.000 description 3
239000000523 sample Substances 0.000 description 3
239000000126 substance Substances 0.000 description 3
YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 2
VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 2
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
206010021143 Hypoxia Diseases 0.000 description 2
241001465754 Metazoa Species 0.000 description 2
239000004909 Moisturizer Substances 0.000 description 2
CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 2
SUHOOTKUPISOBE-UHFFFAOYSA-N O-phosphoethanolamine Chemical compound NCCOP(O)(O)=O SUHOOTKUPISOBE-UHFFFAOYSA-N 0.000 description 2
125000001931 aliphatic group Chemical group 0.000 description 2
210000004369 blood Anatomy 0.000 description 2
239000008280 blood Substances 0.000 description 2
235000014121 butter Nutrition 0.000 description 2
125000004432 carbon atom Chemical group C* 0.000 description 2
ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 2
239000006071 cream Substances 0.000 description 2
230000007812 deficiency Effects 0.000 description 2
230000000694 effects Effects 0.000 description 2
238000009472 formulation Methods 0.000 description 2
150000002270 gangliosides Chemical class 0.000 description 2
239000007789 gas Substances 0.000 description 2
150000002430 hydrocarbons Chemical class 0.000 description 2
239000006210 lotion Substances 0.000 description 2
238000004519 manufacturing process Methods 0.000 description 2
238000005259 measurement Methods 0.000 description 2
230000001333 moisturizer Effects 0.000 description 2
VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
230000007935 neutral effect Effects 0.000 description 2
VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 2
239000002674 ointment Substances 0.000 description 2
206010033675 panniculitis Diseases 0.000 description 2
WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 2
230000002335 preservative effect Effects 0.000 description 2
210000004304 subcutaneous tissue Anatomy 0.000 description 2
235000000346 sugar Nutrition 0.000 description 2
150000008163 sugars Chemical class 0.000 description 2
235000020238 sunflower seed Nutrition 0.000 description 2
230000037373 wrinkle formation Effects 0.000 description 2
DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
OABXUFVTRAEJRN-UHFFFAOYSA-N 1,1-difluorohex-1-ene Chemical compound CCCCC=C(F)F OABXUFVTRAEJRN-UHFFFAOYSA-N 0.000 description 1
LRYZPFWEZHSTHD-HEFFAWAOSA-O 2-[[(e,2s,3r)-2-formamido-3-hydroxyoctadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium Chemical class CCCCCCCCCCCCC\C=C\[C@@H](O)[C@@H](NC=O)COP(O)(=O)OCC[N+](C)(C)C LRYZPFWEZHSTHD-HEFFAWAOSA-O 0.000 description 1
SUBDBMMJDZJVOS-UHFFFAOYSA-N 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole Chemical compound N=1C2=CC(OC)=CC=C2NC=1S(=O)CC1=NC=C(C)C(OC)=C1C SUBDBMMJDZJVOS-UHFFFAOYSA-N 0.000 description 1
WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
XAFPURGXVZDMJH-ZQXPKSBBSA-N CCCCCCCCCCCCCCC(O)[C@@H](O)[C@@H](N)CO.CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@@H](N)CO Chemical group CCCCCCCCCCCCCCC(O)[C@@H](O)[C@@H](N)CO.CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@@H](N)CO XAFPURGXVZDMJH-ZQXPKSBBSA-N 0.000 description 1
ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
244000060011 Cocos nucifera Species 0.000 description 1
235000013162 Cocos nucifera Nutrition 0.000 description 1
241000124008 Mammalia Species 0.000 description 1
OVRNDRQMDRJTHS-CBQIKETKSA-N N-Acetyl-D-Galactosamine Chemical compound CC(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@H](O)[C@@H]1O OVRNDRQMDRJTHS-CBQIKETKSA-N 0.000 description 1
OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
MBLBDJOUHNCFQT-UHFFFAOYSA-N N-acetyl-D-galactosamine Natural products CC(=O)NC(C=O)C(O)C(O)C(O)CO MBLBDJOUHNCFQT-UHFFFAOYSA-N 0.000 description 1
OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
206010029113 Neovascularisation Diseases 0.000 description 1
239000004698 Polyethylene Substances 0.000 description 1
206010063493 Premature ageing Diseases 0.000 description 1
229920000297 Rayon Polymers 0.000 description 1
240000004808 Saccharomyces cerevisiae Species 0.000 description 1
206010072170 Skin wound Diseases 0.000 description 1
230000002378 acidificating effect Effects 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
239000000654 additive Substances 0.000 description 1
230000032683 aging Effects 0.000 description 1
230000001476 alcoholic effect Effects 0.000 description 1
125000000217 alkyl group Chemical group 0.000 description 1
150000001408 amides Chemical class 0.000 description 1
150000001414 amino alcohols Chemical class 0.000 description 1
125000003277 amino group Chemical group 0.000 description 1
230000000202 analgesic effect Effects 0.000 description 1
210000004102 animal cell Anatomy 0.000 description 1
230000000845 anti-microbial effect Effects 0.000 description 1
239000004599 antimicrobial Substances 0.000 description 1
230000004888 barrier function Effects 0.000 description 1
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
210000004204 blood vessel Anatomy 0.000 description 1
210000000133 brain stem Anatomy 0.000 description 1
210000005013 brain tissue Anatomy 0.000 description 1
GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
229910052794 bromium Inorganic materials 0.000 description 1
210000000170 cell membrane Anatomy 0.000 description 1
MSUOLNSQHLHDAS-UHFFFAOYSA-N cerebronic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCCC(O)C(O)=O MSUOLNSQHLHDAS-UHFFFAOYSA-N 0.000 description 1
230000008859 change Effects 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
229910052801 chlorine Inorganic materials 0.000 description 1
239000000460 chlorine Substances 0.000 description 1
210000003763 chloroplast Anatomy 0.000 description 1
230000002950 deficient Effects 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
238000009792 diffusion process Methods 0.000 description 1
150000002016 disaccharides Chemical class 0.000 description 1
201000010099 disease Diseases 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
210000003743 erythrocyte Anatomy 0.000 description 1
238000001704 evaporation Methods 0.000 description 1
230000008020 evaporation Effects 0.000 description 1
210000003722 extracellular fluid Anatomy 0.000 description 1
230000001815 facial effect Effects 0.000 description 1
238000001914 filtration Methods 0.000 description 1
239000012530 fluid Substances 0.000 description 1
210000000245 forearm Anatomy 0.000 description 1
210000004884 grey matter Anatomy 0.000 description 1
125000005843 halogen group Chemical group 0.000 description 1
230000002008 hemorrhagic effect Effects 0.000 description 1
125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
238000010348 incorporation Methods 0.000 description 1
230000000670 limiting effect Effects 0.000 description 1
239000007788 liquid Substances 0.000 description 1
210000004072 lung Anatomy 0.000 description 1
230000007246 mechanism Effects 0.000 description 1
230000004060 metabolic process Effects 0.000 description 1
210000003470 mitochondria Anatomy 0.000 description 1
230000003020 moisturizing effect Effects 0.000 description 1
239000000178 monomer Substances 0.000 description 1
150000002772 monosaccharides Chemical class 0.000 description 1
235000021281 monounsaturated fatty acids Nutrition 0.000 description 1
229950006780 n-acetylglucosamine Drugs 0.000 description 1
210000000653 nervous system Anatomy 0.000 description 1
231100000252 nontoxic Toxicity 0.000 description 1
230000003000 nontoxic effect Effects 0.000 description 1
235000015097 nutrients Nutrition 0.000 description 1
229920001542 oligosaccharide Polymers 0.000 description 1
150000002482 oligosaccharides Chemical class 0.000 description 1
239000006072 paste Substances 0.000 description 1
235000011837 pasties Nutrition 0.000 description 1
230000000149 penetrating effect Effects 0.000 description 1
230000035515 penetration Effects 0.000 description 1
WTWWXOGTJWMJHI-UHFFFAOYSA-N perflubron Chemical compound FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)Br WTWWXOGTJWMJHI-UHFFFAOYSA-N 0.000 description 1
229960001217 perflubron Drugs 0.000 description 1
RVZRBWKZFJCCIB-UHFFFAOYSA-N perfluorotributylamine Chemical compound FC(F)(F)C(F)(F)C(F)(F)C(F)(F)N(C(F)(F)C(F)(F)C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F RVZRBWKZFJCCIB-UHFFFAOYSA-N 0.000 description 1
230000002093 peripheral effect Effects 0.000 description 1
239000008194 pharmaceutical composition Substances 0.000 description 1
239000000546 pharmaceutical excipient Substances 0.000 description 1
YHHSONZFOIEMCP-UHFFFAOYSA-O phosphocholine Chemical compound C[N+](C)(C)CCOP(O)(O)=O YHHSONZFOIEMCP-UHFFFAOYSA-O 0.000 description 1
229950004354 phosphorylcholine Drugs 0.000 description 1
210000002381 plasma Anatomy 0.000 description 1
210000002706 plastid Anatomy 0.000 description 1
229920000573 polyethylene Polymers 0.000 description 1
239000000843 powder Substances 0.000 description 1
230000002028 premature Effects 0.000 description 1
230000009467 reduction Effects 0.000 description 1
230000002829 reductive effect Effects 0.000 description 1
230000008929 regeneration Effects 0.000 description 1
238000011069 regeneration method Methods 0.000 description 1
230000000241 respiratory effect Effects 0.000 description 1
230000002441 reversible effect Effects 0.000 description 1
229920006395 saturated elastomer Polymers 0.000 description 1
230000008591 skin barrier function Effects 0.000 description 1
206010040882 skin lesion Diseases 0.000 description 1
231100000444 skin lesion Toxicity 0.000 description 1
239000007787 solid Substances 0.000 description 1
239000002904 solvent Substances 0.000 description 1
238000001228 spectrum Methods 0.000 description 1
OTKJDMGTUTTYMP-ZWKOTPCHSA-N sphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@@H](N)CO OTKJDMGTUTTYMP-ZWKOTPCHSA-N 0.000 description 1
150000003410 sphingosines Chemical class 0.000 description 1
239000007921 spray Substances 0.000 description 1
239000003381 stabilizer Substances 0.000 description 1
150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
239000000725 suspension Substances 0.000 description 1
TXEYQDLBPFQVAA-UHFFFAOYSA-N tetrafluoromethane Chemical compound FC(F)(F)F TXEYQDLBPFQVAA-UHFFFAOYSA-N 0.000 description 1
230000000699 topical effect Effects 0.000 description 1
235000021122 unsaturated fatty acids Nutrition 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/14—Liposomes; Vesicles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/22—Peroxides; Oxygen; Ozone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/31—Hydrocarbons
- A61K8/315—Halogenated hydrocarbons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/68—Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/69—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing fluorine
- A61K8/70—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing fluorine containing perfluoro groups, e.g. perfluoroethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Birds (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Dermatology (AREA)
Pharmacology & Pharmacy (AREA)
Inorganic Chemistry (AREA)
Dispersion Chemistry (AREA)
Emergency Medicine (AREA)
Cosmetics (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

ZA200601179A 2003-08-11 2004-08-04 Cosmetic composition promoting oxygen transport into the skin ZA200601179B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE10336841A DE10336841A1 (de)	2003-08-11	2003-08-11	Kosmetische Zusammensetzung zur Unterstützung des Sauerstofftransports in die Haut

Publications (1)

Publication Number	Publication Date
ZA200601179B true ZA200601179B (en)	2007-04-25

Family

ID=34177447

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200601179A ZA200601179B (en)	2003-08-11	2004-08-04	Cosmetic composition promoting oxygen transport into the skin

Country Status (10)

Country	Link
US (1)	US20070098662A1 (pl)
EP (1)	EP1673068B1 (pl)
CN (1)	CN1835736A (pl)
AT (1)	ATE450242T1 (pl)
CA (1)	CA2534551C (pl)
DE (2)	DE10336841A1 (pl)
ES (1)	ES2334794T3 (pl)
PL (1)	PL1673068T3 (pl)
WO (1)	WO2005016309A1 (pl)
ZA (1)	ZA200601179B (pl)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10342449A1 (de) *	2003-09-13	2005-04-07	Beiersdorf Ag	Verwendung von Sauerstoff in kosmetischen oder dermatologischen Zubereitungen
CN101443272A (zh) *	2006-05-15	2009-05-27	弗吉尼亚联邦大学	用于受控和持续产生并输送过氧化物的方法和组合物
WO2008103138A1 (en) *	2007-02-23	2008-08-28	Rutherford Chemicals Llc	Shea butter polyoxyalkylene glycol esters
WO2008103137A1 (en) *	2007-02-23	2008-08-28	Rutherford Chemicals Llc	Shea butter alkoxylates
WO2009102487A2 (en) *	2008-02-13	2009-08-20	Oxygen Biotherapeutics, Inc.	Gas based wound and tissue therapeutics
US8343515B2 (en) *	2008-11-25	2013-01-01	Oxygen Biotherapeutics, Inc.	Perfluorocarbon gel formulations
US20100144597A1 (en) *	2008-12-10	2010-06-10	Ward Kevin R	Novel combinatorial approaches to enhancing oxygen transport to tissues
DE102009001710A1 (de) *	2009-03-20	2010-09-23	Rovi Cosmetics International Gmbh	Kosmetische Zusammensetzung mit Wirkstoffen zur Reduktion von Hautfalten und/oder Reduktion der Tiefe von Hautporen
US20100267842A1 (en) *	2009-04-15	2010-10-21	Richard Kiral	Emulsions of Perfluorocarbons
DE102009026718A1 (de)	2009-06-04	2010-04-15	Henkel Ag & Co. Kgaa	Hautbehandlung zur Porenverfeinerung II
WO2011014247A1 (en) *	2009-07-28	2011-02-03	Oxygen Biotherapeutics, Inc.	Method to increase oxygen in male and female sexual organs through the topical use of perfluorocarbons
EP2547201A1 (en) *	2010-03-19	2013-01-23	Oxygen Biotherapeutics, Inc.	Perfluorocarbon eye cream formulations
DE102010044674B9 (de)	2010-09-08	2014-05-15	Meddrop Technology Ag	Perkutanes Applikationssystem
WO2012044963A2 (en)	2010-10-01	2012-04-05	Oxygen Biotherapeutics, Inc.	Perfluorocarbons for use in treating pruritus
CN102008442A (zh) *	2010-12-14	2011-04-13	上海纳米技术及应用国家工程研究中心有限公司	氟碳化合物囊泡载药制剂的制备方法
EP2708264B1 (de)	2012-09-13	2017-10-04	PM-International AG	Kosmetisches Zweikomponenten-Präparat zur getrennten Lagerung von Zubereitungen enthaltend Liposomen enthaltend Coenzym Q10 bzw. Fluorocarbone
PL221284B1 (pl) *	2013-05-27	2016-03-31	Kurek Janusz Alpa Dystrybucja	Kompozycja farmaceutyczna w formie aerozolu i sposób sporządzania kompozycji farmaceutycznej
JP7523908B2 (ja)	2017-02-08	2024-07-29	ユニリーバー・アイピー・ホールディングス・ベスローテン・ヴェンノーツハップ	キサンタン構造化高ポリオール液体クレンザ
DE102018009781A1 (de)	2018-12-13	2020-06-18	Valeopharm GmbH	Verschäumbare wässrige Zubereitungen auf natürlicher Biopolymerbasis mit einsatzflexibler Gas(- vor allem Sauerstoffgas)-Speicherzellen-Verteilung
CN111700833A (zh) *	2020-07-13	2020-09-25	黄伟	一种修复高原红皮肤的面霜及其制备方法与应用

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3642549A (en) *	1969-01-15	1972-02-15	Ibm	Etching composition indication
US3645390A (en) *	1969-08-07	1972-02-29	Robert F Ryan	Diazo copying machine roll cleaner package
JPS5133911B2 (pl) *	1972-06-24	1976-09-22
DE3049665T1 (de) *	1979-06-25	1982-03-18	Suntech	Use of perfluorocarbon as burn treatment
EP0043327B1 (fr) *	1980-07-01	1984-01-18	L'oreal	Procédé d'obtention de dispersions stables dans une phase aqueuse d'au moins une phase liquide non miscible à l'eau et dispersions correspondantes
US4569784A (en) *	1980-11-17	1986-02-11	Adamantech, Inc.	Preparation of a gel having gas transporting capability
FR2627385B3 (fr) *	1988-02-23	1991-08-23	Serobiologiques Lab Sa	Composition notamment utile comme matiere de base pour la preparation de compositions pharmaceutiques, notamment dermatologiques et/ou cosmetiques
US5776470A (en) *	1988-05-06	1998-07-07	Schmidt; Karlheinz	Method of using lipid transfer proteins and lipids to reconstitute membranes
AU647372B2 (en) *	1989-07-05	1994-03-24	Alliance Pharmaceutical Corporation	Fluorocarbon emulsions having saturated phospholipid emulsifiers
US5705187A (en) *	1989-12-22	1998-01-06	Imarx Pharmaceutical Corp.	Compositions of lipids and stabilizing materials
US5733572A (en) *	1989-12-22	1998-03-31	Imarx Pharmaceutical Corp.	Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles
FR2673179B1 (fr) *	1991-02-21	1993-06-11	Oreal	Ceramides, leur procede de preparation et leurs applications en cosmetique et en dermopharmacie.
FR2674748B1 (fr) *	1991-04-03	1995-01-13	Oreal	Utilisation de sphingolipides dans la preparation d'une composition cosmetique ou dermopharmaceutique protegeant la peau et les cheveux contre les effets nocifs de la pollution atmospherique.
DE4127442C2 (de) *	1991-08-17	1996-08-22	Udo Dr Gros	Wäßrige Dispersion Fluorcarbon enthaltender Phospholipid-Vesikel und ein Verfahren zu ihrer Herstellung
DE4221255C2 (de) *	1992-06-26	1994-09-15	Lancaster Group Ag	Phospholipide enthaltendes Kosmetikum
DE4221268C2 (de) *	1992-06-26	1997-06-12	Lancaster Group Ag	Verwendung eines Dermatikums zur Unterstützung des Sauerstofftransportes in der Haut
DE4221256C2 (de) *	1992-06-26	1997-07-10	Lancaster Group Ag	Galenische Zusammensetzung für die topische Anwendung
DE4325071C2 (de) *	1993-07-19	1995-08-10	Lancaster Group Ag	Präparat zur Durchblutungsförderung
DE4327679A1 (de) *	1993-08-13	1995-02-16	Lancaster Group Ag	Funktionelles sauerstoffhaltiges Präparat
FR2714600B1 (fr) *	1993-12-30	1996-02-09	Oreal	Composition protectrice, nutritive et/ou raffermissante pour le traitement simultané des couches superficielles et profondes de la peau, son utilisation.
WO1995020945A1 (en) *	1994-02-04	1995-08-10	Scotia Lipidteknik Ab	Lipophilic carrier preparations
PT744939E (pt) *	1994-02-04	2003-02-28	Lipocore Holding Ab	Preparacoes em bicamada preparadas a partir de digalactosildiacilglicerol contendo galactolipido
FR2716110B1 (fr) *	1994-02-16	1996-04-05	Roussel Uclaf	Compositions cosmétiques ou pharmaceutiques comprenant des liposomes.
DE4445064C2 (de) *	1994-12-07	1998-07-23	Lancaster Group Gmbh	Kosmetische kaolinhaltige Zubereitung
FR2728164B1 (fr) *	1994-12-14	1997-03-21	Oreal	Composition cosmetique ou dermatologique contenant un melange de ceramides, son utilisation pour hydrater la peau
DE19536504C2 (de) *	1995-09-29	1999-09-23	H Meinert	Verwendung fluorierter Alkane
US6248788B1 (en) *	1996-11-06	2001-06-19	The Regents Of The University Of California	Therapeutic method with capsaicin and capasicin analogs
GB9626463D0 (en) *	1996-12-20	1997-02-05	Procter & Gamble	Packaged personal cleansing product
DE19715478A1 (de) *	1997-04-10	1998-10-15	Lancaster Group Gmbh	Kosmetisches und dermatologisches Mittel auf Basis von hartmagnetischen Teilchen
DE19810999A1 (de) *	1998-03-13	1999-09-16	Dermapharm Gmbh	Verwendung von Sphingosin, Sphingosin-1-Phosphat, Sphingosin-1-Phosphat-Derivaten und/oder deren Gemischen zur Behandlung von entzündlichen Hautkrankheiten
DE19841794A1 (de) *	1998-09-12	2000-03-16	Beiersdorf Ag	Kombinationen von Antiadhäsiva (Ceramide und Sphingosine und Derivate) und Mikrobiziden
FR2793410B1 (fr) *	1999-05-12	2004-10-29	Carilene Lab	Utilisation de lipides peroxydes comme agents destines a prevenir et/ou a traiter les effets irritants d'un principe actif
JP4173944B2 (ja) *	2000-06-29	2008-10-29	株式会社紀文フードケミファ	スフィンゴ糖脂質
DE10106288A1 (de) *	2001-02-02	2002-09-05	Coty Bv	Revitalisierender Wirkkomplex für die Haut

2003
- 2003-08-11 DE DE10336841A patent/DE10336841A1/de not_active Ceased
2004
- 2004-08-04 CN CNA2004800230741A patent/CN1835736A/zh active Pending
- 2004-08-04 EP EP04766408A patent/EP1673068B1/de not_active Expired - Lifetime
- 2004-08-04 ES ES04766408T patent/ES2334794T3/es not_active Expired - Lifetime
- 2004-08-04 CA CA2534551A patent/CA2534551C/en not_active Expired - Fee Related
- 2004-08-04 US US10/567,631 patent/US20070098662A1/en not_active Abandoned
- 2004-08-04 PL PL04766408T patent/PL1673068T3/pl unknown
- 2004-08-04 WO PCT/EP2004/051702 patent/WO2005016309A1/de not_active Ceased
- 2004-08-04 ZA ZA200601179A patent/ZA200601179B/en unknown
- 2004-08-04 DE DE502004010463T patent/DE502004010463D1/de not_active Expired - Lifetime
- 2004-08-04 AT AT04766408T patent/ATE450242T1/de not_active IP Right Cessation

Also Published As

Publication number	Publication date
ATE450242T1 (de)	2009-12-15
DE502004010463D1 (de)	2010-01-14
CA2534551C (en)	2012-04-24
US20070098662A1 (en)	2007-05-03
WO2005016309A1 (de)	2005-02-24
EP1673068A1 (de)	2006-06-28
CN1835736A (zh)	2006-09-20
EP1673068B1 (de)	2009-12-02
PL1673068T3 (pl)	2010-03-31
CA2534551A1 (en)	2005-02-24
ES2334794T3 (es)	2010-03-16
DE10336841A1 (de)	2005-03-17

Publication	Publication Date	Title
CA2534551C (en)	2012-04-24	Cosmetic composition to assist transport of oxygen into the skin
US4760096A (en)	1988-07-26	Moisturizing skin preparation
KR100617929B1 (ko)	2006-08-30	환원된 조효소 ｑ 의 안정한 용액
JP5695308B2 (ja)	2015-04-01	コラーゲン修飾リポソームからなる化粧料基剤およびそれを含有する皮膚化粧料
EP3586821B1 (en)	2021-12-01	Stem cell stimulating compositions and methods
HUT71728A (en)	1996-01-29	Slimming composition for topical treatment, containing two types of liposomes, and use thereof
JP2020515635A (ja)	2020-05-28	医薬組成物
FR2714597A1 (fr)	1995-07-07	Composition hydratante pour le traitement simultané des couches superficielles et profondes de la peau, son utilisation.
KR101355216B1 (ko)	2014-01-28	경피 흡수 촉진용 리포좀을 포함하는 조성물이 적용된 마스크 시트
KR20130134532A (ko)	2013-12-10	피부 자극 완화 및 피부 장벽 회복을 위한 다중층 액정 베지클 및 이를 포함하는 화장료 조성물
KR101577874B1 (ko)	2015-12-15	당세라마이드를 함유하는 피부 유사 지질 조성을 갖는 액정상 화장료 조성물 및 그 제조방법
KR101176523B1 (ko)	2012-08-24	성상 변화를 갖는 화장료 조성물
EP2769709B1 (en)	2018-03-28	Pseudolipid complex mixture and a skin external application composition containing same
KR102052621B1 (ko)	2019-12-06	각질층의 라멜라구조와 동일한 구조를 형성하는 유사 피부 모사체의 제조방법 및 이를 함유하는 화장료 조성물
KR20110037863A (ko)	2011-04-13	옥사졸리딘-2-온 화합물을 캡슐화한 리포좀
KR20190070644A (ko)	2019-06-21	액정형성능력이 우수한 유화제 조성물 및 이를 함유하는 화장료 조성물
KR100385457B1 (ko)	2003-05-27	리포좀 화장료 조성물 및 이를 제조하는 방법
KR20170045430A (ko)	2017-04-27	식초를 포함하는 리포좀 조성물, 이의 제조방법 및 상기 리포좀 조성물을 함유하는 화장료 조성물
KR100748035B1 (ko)	2007-08-09	비인지질 베지클로 포집된 유용성분을 함유하는 화장료조성물
JP2006151818A (ja)	2006-06-15	皮膚化粧料
KR102015890B1 (ko)	2019-08-29	폴리사카라이드 액정 조성물과 그 제조방법 및 이를 포함하는 화장료 조성물
JP2022092861A (ja)	2022-06-23	セラミド含有リポソーム
JP2006342351A (ja)	2006-12-21	皮膚水分含有量を調節および改善するためのスクレログルカン解重合物
HK1095537A (en)	2007-05-11	Cosmetic composition promoting oxygen transport into the skin
KR102751247B1 (ko)	2025-01-13	마이크로니들 및 탄성 리포좀을 포함하는 유효성분 전달 시스템